A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

NCT00530764 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Palliative Care
Pain
Cancer

Interventions

DRUG: Sativex Low Dose
DRUG: Sativex Medium Dose
DRUG: Sativex High Dose

Sponsor

GW Pharmaceuticals Ltd

Collaborators

[object Object]